Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 8—August 2006

Research

Antibody Response to Pneumocystis jirovecii

Kieran R. Daly*†, Laurence Huang‡, Alison Morris§, Judy Koch*†, Kristina Crothers‡¶, Linda Levin†, Shary Eiser‡, Supriya Satwah†, Patrizia Zucchi‡#, and Peter D. Walzer*†Comments to Author 
Author affiliations: *Veterans Affairs Medical Center, Cincinnati, Ohio, USA; †University of Cincinnati, Cincinnati, Ohio, USA; ‡University of California, San Francisco, California, USA; §University of Southern California, Los Angeles, California, USA; ¶Yale University School of Medicine, New Haven, Connecticut, USA; #University of Pavia, Pavia, Italy

Main Article

Figure

Figure. Sequential serum antibody responses to major surface glycoprotein C (MsgC) in HIV-positive patients with pneumocystosis. Patients 1 and 2: antibody levels rose from 21.6 and 3.2 at baseline (point 0) to 55.8 and 23.1 at 3–4 weeks and fell to 36.9 and 4.3, respectively, at 7–8 weeks; patient 3: antibody level showed few changes from baseline until it rose to 77.1 at 5–6 weeks; patient 4: antibody level remained at baseline level of 1.0 throughout.

Main Article

TOP